BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34695851)

  • 1. COVID-19: Cardio-pulmonary and Vascular Manifestations.
    Gawaz M; Scharf RE
    Hamostaseologie; 2021 Oct; 41(5):347-348. PubMed ID: 34695851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
    Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
    Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.
    Silva Andrade B; Siqueira S; de Assis Soares WR; de Souza Rangel F; Santos NO; Dos Santos Freitas A; Ribeiro da Silveira P; Tiwari S; Alzahrani KJ; Góes-Neto A; Azevedo V; Ghosh P; Barh D
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33919537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation.
    Mehta OP; Bhandari P; Raut A; Kacimi SEO; Huy NT
    Front Public Health; 2020; 8():582932. PubMed ID: 33520910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications.
    Vrints CJM; Krychtiuk KA; Van Craenenbroeck EM; Segers VF; Price S; Heidbuchel H
    Acta Cardiol; 2021 Apr; 76(2):109-124. PubMed ID: 33208052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications.
    Habashi NM; Camporota L; Gatto LA; Nieman G
    J Appl Physiol (1985); 2021 Mar; 130(3):877-891. PubMed ID: 33444117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry.
    Gómez-Mesa JE; Galindo-Coral S; Montes MC; Alarco W; Barisani JL; Magaña A; Perna ER; Romero A; Speranza M; Mendoza I; Wyss F
    Glob Heart; 2021 Feb; 16(1):14. PubMed ID: 33833938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.
    Rezaei Z; Mobasheri L; Sadri F
    DNA Cell Biol; 2021 Jul; 40(7):858-868. PubMed ID: 33989051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review.
    Menezes MCS; Pestana DVS; Gameiro GR; da Silva LFF; Baron Ė; Rouby JJ; Auler JOC
    Crit Care; 2021 Feb; 25(1):53. PubMed ID: 33557908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiology and COVID-19: do we have sufficient information?
    Garg N; McClafferty B; Ramgobin D; Golamari R; Jain R; Jain R
    Future Cardiol; 2021 Jul; 17(4):705-711. PubMed ID: 33124920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Review of Cardiovascular Involvement in COVID-19.
    Cajanding RJM
    AACN Adv Crit Care; 2021 Jun; 32(2):169-187. PubMed ID: 33836538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury.
    Homme RP; George AK; Singh M; Smolenkova I; Zheng Y; Pushpakumar S; Tyagi SC
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure SARS-CoV-2 related AVDS (Acute Vascular Distress Syndrome).
    Jounieaux V; Basille D; Abou-Arab O; Guillaumont MP; Andrejak C; Mahjoub Y; Rodenstein DO
    BMC Infect Dis; 2021 Jan; 21(1):122. PubMed ID: 33509109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and the Heart.
    Rojulpote C; Gonuguntla K; Patil S; Bhattaru A; Bravo PE
    Colomb Med (Cali); 2020 Jun; 51(2):e4320. PubMed ID: 33012891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and cardiovascular diseases.
    Liu F; Liu F; Wang L
    J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
    Shi X; Chen M; Zhang Y
    Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.